119 related articles for article (PubMed ID: 38615475)
1. Design, synthesis, docking, and antiviral evaluation of some novel pyrimidinone-based α-aminophosphonates as potent H1N1 and HCoV-229E inhibitors.
Hekal HA; Hammad OM; El-Brollosy NR; Salem MM; Allayeh AK
Bioorg Chem; 2024 Jun; 147():107353. PubMed ID: 38615475
[TBL] [Abstract][Full Text] [Related]
2. Antiviral activity of furanocoumarins isolated from Angelica dahurica against influenza a viruses H1N1 and H9N2.
Lee BW; Ha TKQ; Cho HM; An JP; Kim SK; Kim CS; Kim E; Oh WK
J Ethnopharmacol; 2020 Sep; 259():112945. PubMed ID: 32389854
[TBL] [Abstract][Full Text] [Related]
3. In search of effective H1N1 neuraminidase inhibitor by molecular docking, antiviral evaluation and membrane interaction studies using NMR.
Malbari K; Gonsalves H; Chintakrindi A; Gohil D; Joshi M; Kothari S; Srivastava S; Chowdhary A; Kanyalkar M
Acta Virol; 2018; 62(2):179-190. PubMed ID: 29895159
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and bioassay of 4-thiazolinone derivatives as influenza neuraminidase inhibitors.
Xiao M; Xu L; Lin D; Lian W; Cui M; Zhang M; Yan X; Li S; Zhao J; Ye J; Liu A; Hu A
Eur J Med Chem; 2021 Mar; 213():113161. PubMed ID: 33540229
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of substituted flavones and aurones as potential anti-influenza agents.
Chintakrindi AS; Gohil DJ; Chowdhary AS; Kanyalkar MA
Bioorg Med Chem; 2020 Jan; 28(1):115191. PubMed ID: 31744778
[TBL] [Abstract][Full Text] [Related]
6. Neuraminidase from Influenza A and B Viruses is Susceptible to the Compound 4-(4-Phenyl-1H-1,2,3-Triazol-1-yl)-2,2,6,6-Tetramethylpiperidine-1- Oxyl.
Sacramento CQ; Jordão AK; Abrantes JL; Alves CM; Marttorelli A; Fintelman-Rodrigues N; de Freitas CS; de Melo GR; Cunha AC; Ferreira VF; Souza TML
Curr Top Med Chem; 2020; 20(2):132-139. PubMed ID: 31880262
[TBL] [Abstract][Full Text] [Related]
7. Discovery of acylguanidine oseltamivir carboxylate derivatives as potent neuraminidase inhibitors.
Li Z; Meng Y; Xu S; Shen W; Meng Z; Wang Z; Ding G; Huang W; Xiao W; Xu J
Bioorg Med Chem; 2017 May; 25(10):2772-2781. PubMed ID: 28385598
[TBL] [Abstract][Full Text] [Related]
8. 3D-quantitative structure-activity relationship and antiviral effects of curcumin derivatives as potent inhibitors of influenza H1N1 neuraminidase.
Lai Y; Yan Y; Liao S; Li Y; Ye Y; Liu N; Zhao F; Xu P
Arch Pharm Res; 2020 May; 43(5):489-502. PubMed ID: 32248350
[TBL] [Abstract][Full Text] [Related]
9. Studies on synthesis and structure-activity relationship (SAR) of derivatives of a new natural product from marine fungi as inhibitors of influenza virus neuraminidase.
Li J; Zhang D; Zhu X; He Z; Liu S; Li M; Pang J; Lin Y
Mar Drugs; 2011; 9(10):1887-1901. PubMed ID: 22073001
[TBL] [Abstract][Full Text] [Related]
10. Discovery of Novel Pyrazole Derivatives as Potent Neuraminidase Inhibitors against Influenza H1N1 Virus.
Meng FJ; Sun T; Dong WZ; Li MH; Tuo ZZ
Arch Pharm (Weinheim); 2016 Mar; 349(3):168-74. PubMed ID: 26797880
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of novel zanamivir derivatives as potent neuraminidase inhibitors.
Cheng LP; Wang TC; Yu R; Li M; Huang JW
Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3622-3629. PubMed ID: 30389293
[TBL] [Abstract][Full Text] [Related]
12. Design and one-pot synthesis of 2-thiazolylhydrazone derivatives as influenza neuraminidase inhibitors.
Yuan K; Xiao M; Tan Y; Ye J; Xie Y; Sun X; Hu A; Lian W; Liu A
Mol Divers; 2017 Aug; 21(3):565-576. PubMed ID: 28536876
[TBL] [Abstract][Full Text] [Related]
13. Bioassay of ferulic acid derivatives as influenza neuraminidase inhibitors.
Cui MY; Xiao MW; Xu LJ; Chen Y; Liu AL; Ye J; Hu AX
Arch Pharm (Weinheim); 2020 Jan; 353(1):e1900174. PubMed ID: 31657061
[TBL] [Abstract][Full Text] [Related]
14. Design, Synthesis, and Antiviral Activity of Novel Ribonucleosides of 1,2,3-Triazolylbenzyl-aminophosphonates.
Ouahrouch A; Taourirte M; Schols D; Snoeck R; Andrei G; Engels JW; Lazrek HB
Arch Pharm (Weinheim); 2016 Jan; 349(1):30-41. PubMed ID: 26575425
[TBL] [Abstract][Full Text] [Related]
15. In vitro antiviral effects and 3D QSAR study of resveratrol derivatives as potent inhibitors of influenza H1N1 neuraminidase.
Li C; Fang JS; Lian WW; Pang XC; Liu AL; Du GH
Chem Biol Drug Des; 2015 Apr; 85(4):427-38. PubMed ID: 25185493
[TBL] [Abstract][Full Text] [Related]
16. Novel N-Substituted oseltamivir derivatives as potent influenza neuraminidase inhibitors: Design, synthesis, biological evaluation, ADME prediction and molecular docking studies.
Ye J; Yang X; Xu M; Chan PK; Ma C
Eur J Med Chem; 2019 Nov; 182():111635. PubMed ID: 31493744
[TBL] [Abstract][Full Text] [Related]
17. Structure-aided drug development of potential neuraminidase inhibitors against pandemic H1N1 exploring alternate binding mechanism.
Malbari KD; Chintakrindi AS; Ganji LR; Gohil DJ; Kothari ST; Joshi MV; Kanyalkar MA
Mol Divers; 2019 Nov; 23(4):927-951. PubMed ID: 30710224
[TBL] [Abstract][Full Text] [Related]
18. Molecular modeling and lead design of substituted zanamivir derivatives as potent anti-influenza drugs.
Dholakia D; Goyal S; Jamal S; Singh A; Das A; Grover A
BMC Bioinformatics; 2016 Dec; 17(Suppl 19):512. PubMed ID: 28155702
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of acylguanidine zanamivir derivatives as neuraminidase inhibitors and the evaluation of their bio-activities.
Lin CH; Chang TC; Das A; Fang MY; Hung HC; Hsu KC; Yang JM; von Itzstein M; Mong KK; Hsu TA; Lin CC
Org Biomol Chem; 2013 Jun; 11(24):3943-8. PubMed ID: 23695381
[TBL] [Abstract][Full Text] [Related]
20. Understanding the cross-resistance of oseltamivir to H1N1 and H5N1 influenza A neuraminidase mutations using multidimensional computational analyses.
Singh A; Soliman ME
Drug Des Devel Ther; 2015; 9():4137-54. PubMed ID: 26257512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
